John Armando

John Armando is a regulatory professional with 12 years of regulatory and technical development industry experience. In his current role, John is a member of the Pharma Technical Regulatory group at Genentech, Inc. supporting marketed products. Prior to joining Genentech, John was a member of the Regulatory CMC groups at Agios Pharmaceuticals and Biogen providing regulatory strategy for early and late stage development products for biologics, oligonucleotides, small molecules, and gene therapy products. Before moving into regulatory affairs, John was a technical development engineer focusing on downstream purification process development for biologics. John holds an MS and BS in Chemical and Biological Engineering from Tufts University and an MS in Regulatory Affairs from Northeastern University, and is RAC-US certified. John is most interested in regulatory reliance, emerging technologies, and post-approval lifecycle management.